Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| enterocyte | 8 studies | 40% ± 18% | |
| epithelial cell | 6 studies | 45% ± 18% | |
| goblet cell | 5 studies | 35% ± 8% | |
| progenitor cell | 5 studies | 37% ± 10% | |
| enteroendocrine cell | 4 studies | 25% ± 7% | |
| transit amplifying cell | 4 studies | 29% ± 8% | |
| brush cell | 4 studies | 34% ± 6% | |
| intestinal crypt stem cell | 3 studies | 30% ± 10% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| intestine | 6 studies | 21% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| intestine | 100% | 12245.96 | 963 / 966 | 92% | 410.93 | 484 / 527 |
| stomach | 85% | 24.83 | 306 / 359 | 83% | 325.95 | 237 / 286 |
| pancreas | 77% | 33.99 | 253 / 328 | 56% | 61.21 | 100 / 178 |
| esophagus | 93% | 53.57 | 1348 / 1445 | 39% | 98.88 | 72 / 183 |
| bladder | 81% | 42.19 | 17 / 21 | 25% | 110.27 | 125 / 504 |
| uterus | 92% | 31.19 | 156 / 170 | 6% | 6.83 | 26 / 459 |
| prostate | 94% | 51.99 | 230 / 245 | 2% | 0.83 | 10 / 502 |
| blood vessel | 93% | 35.68 | 1245 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 93% | 52.18 | 224 / 241 | 0% | 0 | 0 / 0 |
| kidney | 84% | 24.42 | 75 / 89 | 8% | 4.74 | 71 / 901 |
| heart | 68% | 19.40 | 584 / 861 | 0% | 0 | 0 / 0 |
| lung | 50% | 8.86 | 291 / 578 | 17% | 27.14 | 200 / 1155 |
| ovary | 62% | 13.13 | 111 / 180 | 1% | 0.17 | 3 / 430 |
| breast | 59% | 76.80 | 272 / 459 | 0% | 0 | 0 / 1118 |
| adipose | 39% | 5.95 | 473 / 1204 | 0% | 0 | 0 / 0 |
| adrenal gland | 38% | 4.46 | 98 / 258 | 1% | 0.26 | 2 / 230 |
| thymus | 38% | 4.90 | 246 / 653 | 0% | 0 | 0 / 605 |
| liver | 23% | 2.77 | 53 / 226 | 4% | 2.47 | 18 / 406 |
| muscle | 23% | 2.97 | 182 / 803 | 0% | 0 | 0 / 0 |
| brain | 23% | 2.61 | 595 / 2642 | 0% | 0 | 0 / 705 |
| skin | 22% | 2.86 | 390 / 1809 | 0% | 0.10 | 2 / 472 |
| peripheral blood | 19% | 28.98 | 172 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0007043 | Biological process | cell-cell junction assembly |
| GO_0034332 | Biological process | adherens junction organization |
| GO_0035672 | Biological process | oligopeptide transmembrane transport |
| GO_0007275 | Biological process | multicellular organism development |
| GO_0007155 | Biological process | cell adhesion |
| GO_0044331 | Biological process | cell-cell adhesion mediated by cadherin |
| GO_0048536 | Biological process | spleen development |
| GO_0002315 | Biological process | marginal zone B cell differentiation |
| GO_0002314 | Biological process | germinal center B cell differentiation |
| GO_0006857 | Biological process | oligopeptide transport |
| GO_0007229 | Biological process | integrin-mediated signaling pathway |
| GO_0007156 | Biological process | homophilic cell adhesion via plasma membrane adhesion molecules |
| GO_0016339 | Biological process | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules |
| GO_0000902 | Biological process | cell morphogenesis |
| GO_0033626 | Biological process | positive regulation of integrin activation by cell surface receptor linked signal transduction |
| GO_0016477 | Biological process | cell migration |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0016342 | Cellular component | catenin complex |
| GO_0009986 | Cellular component | cell surface |
| GO_0005912 | Cellular component | adherens junction |
| GO_0030054 | Cellular component | cell junction |
| GO_0016323 | Cellular component | basolateral plasma membrane |
| GO_0045296 | Molecular function | cadherin binding |
| GO_0008013 | Molecular function | beta-catenin binding |
| GO_0005178 | Molecular function | integrin binding |
| GO_0005427 | Molecular function | proton-dependent oligopeptide secondary active transmembrane transporter activity |
| GO_0005509 | Molecular function | calcium ion binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | CDH17 |
| Protein name | Cadherin 17 Cadherin-17 (Intestinal peptide-associated transporter HPT-1) (Liver-intestine cadherin) (LI-cadherin) |
| Synonyms | |
| Description | FUNCTION: Cadherins are calcium-dependent cell adhesion proteins. They preferentially interact with themselves in a homophilic manner in connecting cells; cadherins may thus contribute to the sorting of heterogeneous cell types. LI-cadherin may have a role in the morphological organization of liver and intestine. Involved in intestinal peptide transport. . |
| Accessions | ENST00000521491.1 Q12864 E5RJT3 ENST00000441892.6 E7EN24 ENST00000027335.8 ENST00000520952.1 H0YBL0 ENST00000450165.6 |
